Glytec Publishes First COVID-19 Research to Study the ‘Opportunity Window’ for Treating Hospitalized Patients with Diabetes or Hyperglycemia New Research Published in Diabetes Care Journal Reveals 7x Mortality Risk for Non-ICU Patients with Severe Hyperglycemia After 2-3 Days, Indicating Need to Start Treatment on Admission WALTHAM, MASS. (December 15, 2020) – Glytec, the only provider of insulin management software across the …
Glytec Leads ADCES Webinar on Inpatient Glycemic Management During COVID-19 Live Session and Q&A on December 10 Features Case Studies from Diabetes Care and Education Specialists WALTHAM, MASS. (December 1, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today announced it is partnering with the Association of Diabetes Care & Education Specialists (ADCES) to …
Sarasota Memorial Health Care System Chooses Glytec to Enhance Diabetes Care Insulin Management Software Supports System-Wide Glycemic Best Practices with a Personalized Approach to Dosing that Prioritizes Patient Safety WALTHAM, MASS. (November 17, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today announced that Sarasota Memorial Health Care System (SMH) selected its eGlycemic Management …
The May 30, 2019 webinar will explore the keys to augmenting traditional brick-and-mortar care with virtual care for people with diabetes.
Managing the care of people with diabetes is costly and time intensive, especially for our nation’s primary care providers who shoulder 80% of that responsibility. Virtual care programs have the potential to fill critical gaps and meet increasing demands, but can they produce real results?
The Dario® Blood Glucose Monitoring System will be made available to hospitals and health systems using Glytec’s virtual insulin titration service for outpatients with diabetes.
Global digital therapeutics innovator, DarioHealth Corp. (Nasdaq: DRIO), today announced a joint marketing agreement with Glytec, the market leader and pioneer of insulin titration solutions for use across the full continuum of care. The agreement allows DarioHealth’s smart glucose meter (part of the Dario Blood Glucose Monitoring System) to transmit information to Glytec’s Glucommander™ Outpatient software-as-a-medical-device.
The iGlucose® Cell-Enabled Diabetes Care Solution from Smart Meter is now compatible with Glytec’s virtual insulin titration service.
For millions of patients with diabetes who’ve been unable to achieve their treatment goals, few programs have the potential to reduce A1C faster or more effectively than Glytec’s virtual insulin titration service. The innovative service harnesses the integration of Glytec’s Glucommander™ Outpatient software with multiple connected diabetes technologies and health information systems, including those for blood glucose measurement, insulin delivery, medical record keeping and patient communication, among others. The latest company to join Glytec’s network of connected solution partners is Smart Meter, LLC, maker of the iGlucose® Cell-Enabled Diabetes Care Solution, bringing timely, complete and accurate data to insulin titration.
The integrated solution will launch in pilot programs with select U.S. providers and payers early 2018.
Glytec is pleased to announce its Glucommander™ Outpatient will be integrated with Onduo’s virtual diabetes clinic to help people with type 2 diabetes more easily manage insulin therapy and achieve their glucose targets. Onduo, a joint venture of Sanofi and Verily (an Alphabet company), is developing a virtual platform that integrates hardware, such as wirelessly-connected continuous glucose monitors, software and personalized support from healthcare experts to help people manage their type 2 diabetes. The integrated solution will launch in pilot programs with select U.S. providers and payers early 2018.
AgaMatrix, Inc. and Glytec announced today they are partnering to optimize clinical access to accurate glucose data and insulin titration support through a cloud-based diabetes management platform.
AgaMatrix is integrating their FDA-cleared Jazz Wireless 2 Bluetooth® Blood Glucose Monitoring System with Glytec’s eGlycemic Management System® (eGMS®), featuring FDA-cleared Glucommander™ for evidence-based insulin dosing decision support. By automatically transferring patient blood glucose data from the AgaMatrix Diabetes Manager App to eGMS®, health care professionals are able to deliver personalized diabetes therapy management in a virtual setting. The two companies are actively engaged in a pilot of this integrated solution.
Livongo goes deeper into medication optimization.
Livongo Health, the leading consumer digital health company focused on empowering people with chronic conditions to live better and healthier lives, today announced a partnership with Glytec to offer eGlycemic Management System®, or eGMS®, to Livongo members. With this alliance, Livongo and Glytec will partner to deliver an expanded diabetes management solution that includes insulin titration, making managing diabetes easier for members and their providers.